We are live on
!
Find out more
FC
Finepoint Capital Portfolio holdings
AUM
$1.95B
1-Year Est. Return
45.61%
This Fund
S&P 500
This Quarter
Est. Return
-9.15%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
–
AUM
$1.74B
AUM Growth
+$383M
(+28%)
Cap. Flow
+$356M
Cap. Flow
% of AUM
20.46%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
3
Reduced
–
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RXO
RXO
|
+$117M |
| 2 |
QXO
QXO Inc
QXO
|
+$23.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Live Group Series C
LLYVK
|
+$43.6M |
| 2 |
LSBPW
LakeShore Biopharma Warrants
LSBPW
|
+$19.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 30.87% |
| 2 | Healthcare | 0.34% |
| 3 | Energy | 0.01% |
| 4 | Communication Services | 0% |
Similar funds
NIM
WPC
SGAM
HA
BC
FFH
NFG
MWA
Finepoint Capital's Q3 2025 Portfolio in Review
As of Q3 2025, Finepoint Capital held 11 positions worth $1.74B, up 28% from $1.36B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Finepoint Capital deployed $356M of net new capital in Q3 2025, opening 1 new position and adding to 3 existing holdings. Its largest new stake was RXO: 7,266,839 shares worth $112M.
By sector, the portfolio is most concentrated in Industrials at 31% of assets, down from 34% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the most notable exit was Liberty Live Group Series C, an estimated $43.6M sold.
- Finepoint Capital's largest Q3 2025 buy was RXO: 7,266,839 shares worth $112M.
- Finepoint Capital added most to QXO Inc in Q3 2025, an estimated $23.7M increase.
- Finepoint Capital fully exited Liberty Live Group Series C in Q3 2025, selling an estimated $43.6M.
- Finepoint Capital's ten largest holdings make up 100% of its $1.74B portfolio in Q3 2025.
- Finepoint Capital opened 1 new position and closed 2 in Q3 2025.
- Finepoint Capital's portfolio value rose 28% quarter-over-quarter to $1.74B.
Based on Finepoint Capital's 13F filing for Q3 2025, filed 13 Nov 2025.